The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Methods Of Treating Chronic Kidney Disease With Dapagliflozin - EP4188389

The patent EP4188389 was granted to Astrazeneca on Sep 17, 2025. The application was originally filed on Apr 1, 2021 under application number EP21716724A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4188389

ASTRAZENECA
Application Number
EP21716724A
Filing Date
Apr 1, 2021
Status
Granted And Under Opposition
Aug 15, 2025
Publication Date
Sep 17, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKSep 17, 2025ELKINGTON AND FIFEADMISSIBLE

Patent Citations (75) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0598359
DESCRIPTIONEP0684254
DESCRIPTIONEP0773226
DESCRIPTIONEP0850948
DESCRIPTIONJP2006117651
DESCRIPTIONJP4359630B
DESCRIPTIONJPH035988
DESCRIPTIONJPH0827006
DESCRIPTIONJPH09124684
DESCRIPTIONJPH09124685
DESCRIPTIONJPH09188625
DESCRIPTIONJPH10245391
DESCRIPTIONUS2003064935
DESCRIPTIONUS2003195235
DESCRIPTIONUS2005119192
DESCRIPTIONUS2005209166
DESCRIPTIONUS2005233982
DESCRIPTIONUS2005233988
DESCRIPTIONUS2006009400
DESCRIPTIONUS2006019948
DESCRIPTIONUS2006025349
DESCRIPTIONUS2006035841
DESCRIPTIONUS2006063722
DESCRIPTIONUS2006074031
DESCRIPTIONUS2006122126
DESCRIPTIONUS2006194809
DESCRIPTIONUS2008090876
DESCRIPTIONUS3983140
DESCRIPTIONUS4231938
DESCRIPTIONUS4346227
DESCRIPTIONUS4448784
DESCRIPTIONUS4450171
DESCRIPTIONUS4572912
DESCRIPTIONUS5488064
DESCRIPTIONUS5491134
DESCRIPTIONUS5541204
DESCRIPTIONUS5594016
DESCRIPTIONUS5612359
DESCRIPTIONUS5731292
DESCRIPTIONUS5753675
DESCRIPTIONUS5767094
DESCRIPTIONUS5770615
DESCRIPTIONUS5776983
DESCRIPTIONUS6043265
DESCRIPTIONUS6048842
DESCRIPTIONUS6395767
DESCRIPTIONUS6414002
DESCRIPTIONUS6414126
DESCRIPTIONUS6515117
DESCRIPTIONUS6515177
DESCRIPTIONUS6548529
DESCRIPTIONUS6555519
DESCRIPTIONUS6683056
DESCRIPTIONUS6774112
DESCRIPTIONUS6815428
DESCRIPTIONUS6908905
DESCRIPTIONUS7015201
DESCRIPTIONUS7919598
DESCRIPTIONWO0001389
DESCRIPTIONWO02083066
DESCRIPTIONWO03099836
DESCRIPTIONWO2005012321
DESCRIPTIONWO2006011469
DESCRIPTIONWO2006035796
DESCRIPTIONWO2006037537
DESCRIPTIONWO2006058597
DESCRIPTIONWO2006080421
DESCRIPTIONWO2008005964
DESCRIPTIONWO2016001631
DESCRIPTIONWO9938501
DESCRIPTIONWO9946272
DESCRIPTIONWO9961431
DESCRIPTIONWO9967278
DESCRIPTIONWO9967279
OPPOSITIONUS2008004336

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents